Stay updated on TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:48:23.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:30:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-30T04:28:00.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T01:23:03.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:51:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed descriptions of a clinical trial for nivolumab in treating advanced transitional cell carcinoma, while adding new collaborators and a revision number.
    Difference
    48%
    Check dated 2025-04-16T14:49:39.000Z thumbnail image

Stay in the know with updates to TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.